CVS Health (NYSE:CVS) Price Target Cut to $97.00 by Analysts at Wolfe Research

CVS Health (NYSE:CVS) had its price objective decreased by research analysts at Wolfe Research from $100.00 to $97.00 in a research report issued on Monday,MarketScreener reports. The brokerage presently has an “outperform” rating on the pharmacy operator’s stock. Wolfe Research’s target price points to a potential upside of 19.84% from the stock’s previous close.

CVS has been the topic of a number of other research reports. Piper Sandler reaffirmed an “overweight” rating and set a $101.00 price objective (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Barclays lifted their price target on shares of CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Wells Fargo & Company reduced their price target on CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a research note on Thursday, November 13th. Argus cut their price target on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. Nineteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.77.

CVS Health Trading Up 1.3%

CVS traded up $1.04 on Monday, hitting $80.94. The company had a trading volume of 667,433 shares, compared to its average volume of 9,276,245. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The business’s fifty day simple moving average is $78.39 and its 200 day simple moving average is $77.29. CVS Health has a 12-month low of $58.35 and a 12-month high of $85.15. The company has a market cap of $102.98 billion, a PE ratio of 58.75, a PEG ratio of 0.83 and a beta of 0.49.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.00 by $0.09. The firm had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. CVS Health’s revenue was up 8.2% on a year-over-year basis. During the same period last year, the firm posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities research analysts expect that CVS Health will post 5.89 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Harbor Capital Advisors Inc. boosted its position in shares of CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its holdings in CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 281 shares during the period. Swiss RE Ltd. acquired a new position in shares of CVS Health in the fourth quarter valued at approximately $26,000. Mcguire Capital Advisors Inc. bought a new position in shares of CVS Health in the fourth quarter worth $28,000. Finally, Corundum Trust Company INC bought a new stake in shares of CVS Health during the third quarter worth $29,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.